Evidence map›Paper›PMID 42328165›Full record

ArticleFrontiers in cellular and infection microbiology2026

Development and evaluation of single-plex TaqMan real-time quantitative PCR assays for the detection of six tick-borne pathogenic viruses in northeastern China.

Shiyao Xu, Zheng Gui, Ziyan Liu, Kai Wang, Ning Liu, Yunzhi Peng, Liang Li, Zedong Wang

Abstract readEvaluation Study
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shiyao Xu *Department of Infectious Diseases, Center of Infectious Diseases and Pathogen Biology, State Key Laboratory of Zoonotic Diseases, the First Hospital of Jilin University, Changchun, Jilin, China.
Zheng Gui *Department of Infectious Diseases, Center of Infectious Diseases and Pathogen Biology, State Key Laboratory of Zoonotic Diseases, the First Hospital of Jilin University, Changchun, Jilin, China.
Ziyan Liu *Department of Infectious Diseases, Center of Infectious Diseases and Pathogen Biology, State Key Laboratory of Zoonotic Diseases, the First Hospital of Jilin University, Changchun, Jilin, China.
Kai WangState Key Laboratory of Pathogen and Biosecurity, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, Jilin, China.
Ning LiuDepartment of Infectious Diseases, Center of Infectious Diseases and Pathogen Biology, State Key Laboratory of Zoonotic Diseases, the First Hospital of Jilin University, Changchun, Jilin, China.
Yunzhi PengDepartment of Infectious Diseases, Center of Infectious Diseases and Pathogen Biology, State Key Laboratory of Zoonotic Diseases, the First Hospital of Jilin University, Changchun, Jilin, China.
Liang LiState Key Laboratory of Pathogen and Biosecurity, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, Jilin, China.
Zedong WangDepartment of Infectious Diseases, Center of Infectious Diseases and Pathogen Biology, State Key Laboratory of Zoonotic Diseases, the First Hospital of Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Northeastern China is a recognized hotspot for tick-borne viral diseases. However, there remains a lack of methods capable of simultaneously detecting these emerging and re-emerging tick-borne viruses. Methods: Primer and probe sets were designed using Beacon Designer 8.0, targeting conserved regions of viral genomes from Alongshan virus (ALSV), Tick-borne encephalitis virus (TBEV), Severe fever with thrombocytopenia syndrome virus (SFTSV), Beiji nairovirus (BJNV), Yezo virus (YEZV), and Songling virus (SGLV). Recombinant plasmids were constructed to assess assay sensitivity, while virus-positive cDNA from tick samples was used to verify specificity. The performance of these assays was further validated using field-collected tick samples, with results compared against established reference methods serving as gold standards. Results: Specific primer and probe sets were designed with amplicon lengths ranging from 83 to 199 bp. Optimization of the reaction components yielded final primer volumes of 0.2-0.5 μL and probe volumes of 0.4-1.0 μL (from 10 μM working stocks). Sensitivity analysis demonstrated a limit of detection (LOD) as low as 10 copies/μL for all six viruses, while specificity testing confirmed no cross-reactivity among the targets. In validation trials, the established TaqMan RT-qPCR assays showed complete concordance with reference methods for ALSV (5/15) and TBEV (4/14). Notably, the TaqMan assays identified additional positive samples for SFTSV (n=1), BJNV (n=3), and YEZV (n=1) that were missed by the reference assays, particularly in samples with low viral loads. Conversely, two samples that tested positive for SGLV using SYBR Green RT-qPCR yielded negative results with the TaqMan RT-qPCR assay. Conclusion: We have successfully developed a suite of highly sensitive and specific single-plex TaqMan RT-qPCR assays for the rapid detection of six key tick-borne viruses in northeastern China. These assays facilitate efficient viral surveillance in tick populations and provide a diagnostic tool with significant potential for clinical applications.

Indexed as

Molecular Diagnostic TechniquesReal-Time Polymerase Chain ReactionTick-Borne DiseasesVirusesAnimalsChinaDNA PrimersHumansOligonucleotide ProbesRNA, ViralSensitivity and SpecificityTicksDNA PrimersOligonucleotide ProbesRNA, Viralnortheastern Chinareal-time quantitative PCR (RT-qPCR)tick-borne diseasestick-borne virusesticks

Identifiers

PMID42328165
PMCPMC13275643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.